Genmab A/S (GMAB)
USD 19.32
(2.71%)
USD 19.32
(2.71%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 16.47 Billion DKK | 12.87% |
| 2022 | 14.59 Billion DKK | 72.07% |
| 2021 | 8.48 Billion DKK | -16.11% |
| 2020 | 10.11 Billion DKK | 88.43% |
| 2019 | 5.36 Billion DKK | 77.38% |
| 2018 | 3.02 Billion DKK | 27.89% |
| 2017 | 2.36 Billion DKK | 30.25% |
| 2016 | 1.81 Billion DKK | 60.29% |
| 2015 | 1.13 Billion DKK | 33.24% |
| 2014 | 850.38 Million DKK | 28.15% |
| 2013 | 663.57 Million DKK | 36.92% |
| 2012 | 484.63 Million DKK | 38.1% |
| 2011 | 350.93 Million DKK | -39.71% |
| 2010 | 582.07 Million DKK | -0.68% |
| 2009 | 586.07 Million DKK | -21.34% |
| 2008 | 745.11 Million DKK | 40.71% |
| 2007 | 529.53 Million DKK | 290.67% |
| 2006 | 135.54 Million DKK | 37.6% |
| 2005 | 98.5 Million DKK | 2301.98% |
| 2004 | 4.1 Million DKK | -94.0% |
| 2003 | 68.32 Million DKK | 0.0% |
| 2002 | - DKK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 4.14 Billion DKK | -11.44% |
| 2024 Q2 | 5.4 Billion DKK | 30.39% |
| 2023 Q4 | 4.67 Billion DKK | -1.39% |
| 2023 Q1 | 2.85 Billion DKK | -45.4% |
| 2023 FY | 16.47 Billion DKK | 12.87% |
| 2023 Q2 | 4.19 Billion DKK | 47.09% |
| 2023 Q3 | 4.74 Billion DKK | 13.01% |
| 2022 FY | 14.59 Billion DKK | 72.07% |
| 2022 Q4 | 5.22 Billion DKK | 27.89% |
| 2022 Q1 | 2.11 Billion DKK | -19.09% |
| 2022 Q2 | 3.16 Billion DKK | 49.22% |
| 2022 Q3 | 4.08 Billion DKK | 29.25% |
| 2021 FY | 8.48 Billion DKK | -16.11% |
| 2021 Q1 | 1.58 Billion DKK | -22.65% |
| 2021 Q3 | 2.31 Billion DKK | 17.14% |
| 2021 Q4 | 2.61 Billion DKK | 13.38% |
| 2021 Q2 | 1.97 Billion DKK | 24.73% |
| 2020 Q3 | 1.72 Billion DKK | -68.37% |
| 2020 FY | 10.11 Billion DKK | 88.43% |
| 2020 Q1 | 892 Million DKK | -69.88% |
| 2020 Q2 | 5.45 Billion DKK | 511.1% |
| 2020 Q4 | 2.04 Billion DKK | 18.56% |
| 2019 Q2 | 773.91 Million DKK | 30.95% |
| 2019 FY | 5.36 Billion DKK | 77.38% |
| 2019 Q4 | 2.96 Billion DKK | 184.78% |
| 2019 Q3 | 1.03 Billion DKK | 34.36% |
| 2019 Q1 | 591 Million DKK | -52.18% |
| 2018 Q3 | 598.59 Million DKK | 17.45% |
| 2018 Q4 | 1.23 Billion DKK | 106.46% |
| 2018 Q1 | 681.01 Million DKK | -33.09% |
| 2018 FY | 3.02 Billion DKK | 27.89% |
| 2018 Q2 | 509.67 Million DKK | -25.16% |
| 2017 FY | 2.36 Billion DKK | 30.25% |
| 2017 Q4 | 1.01 Billion DKK | 214.69% |
| 2017 Q3 | 323.44 Million DKK | -58.18% |
| 2017 Q2 | 773.34 Million DKK | 208.38% |
| 2017 Q1 | 250.77 Million DKK | -72.96% |
| 2016 Q1 | 170.17 Million DKK | -70.39% |
| 2016 FY | 1.81 Billion DKK | 60.29% |
| 2016 Q3 | 364.66 Million DKK | 3.06% |
| 2016 Q2 | 353.82 Million DKK | 107.92% |
| 2016 Q4 | 927.46 Million DKK | 154.33% |
| 2015 FY | 1.13 Billion DKK | 33.24% |
| 2015 Q1 | 106.77 Million DKK | -50.52% |
| 2015 Q4 | 574.65 Million DKK | 106.89% |
| 2015 Q3 | 277.76 Million DKK | 59.78% |
| 2015 Q2 | 173.84 Million DKK | 62.81% |
| 2014 Q4 | 215.8 Million DKK | -20.52% |
| 2014 FY | 850.38 Million DKK | 28.15% |
| 2014 Q3 | 271.52 Million DKK | 134.09% |
| 2014 Q2 | 115.98 Million DKK | -53.06% |
| 2014 Q1 | 247.07 Million DKK | 14.36% |
| 2013 Q1 | 159.77 Million DKK | -2.04% |
| 2013 FY | 663.57 Million DKK | 36.92% |
| 2013 Q4 | 216.04 Million DKK | 44.35% |
| 2013 Q3 | 149.66 Million DKK | 8.38% |
| 2013 Q2 | 138.09 Million DKK | -13.57% |
| 2012 Q4 | 163.1 Million DKK | 40.76% |
| 2012 Q3 | 115.87 Million DKK | 3.79% |
| 2012 Q2 | 111.64 Million DKK | 18.76% |
| 2012 Q1 | 94.01 Million DKK | 1.01% |
| 2012 FY | 484.63 Million DKK | 38.1% |
| 2011 Q2 | 83.87 Million DKK | 0.91% |
| 2011 Q1 | 83.12 Million DKK | -8.81% |
| 2011 Q3 | 90.86 Million DKK | 8.33% |
| 2011 Q4 | 93.06 Million DKK | 2.42% |
| 2011 FY | 350.93 Million DKK | -39.71% |
| 2010 Q3 | 214.59 Million DKK | 26.38% |
| 2010 Q1 | 106.52 Million DKK | -44.78% |
| 2010 Q4 | 91.15 Million DKK | -57.52% |
| 2010 Q2 | 169.8 Million DKK | 59.41% |
| 2010 FY | 582.07 Million DKK | -0.68% |
| 2009 Q4 | 192.89 Million DKK | 179.45% |
| 2009 FY | 586.07 Million DKK | -21.34% |
| 2009 Q2 | 74.17 Million DKK | -70.33% |
| 2009 Q1 | 249.98 Million DKK | 0.0% |
| 2009 Q3 | 69.02 Million DKK | -6.94% |
| 2008 FY | 745.11 Million DKK | 40.71% |
| 2007 FY | 529.53 Million DKK | 290.67% |
| 2006 FY | 135.54 Million DKK | 37.6% |
| 2005 FY | 98.5 Million DKK | 2301.98% |
| 2004 FY | 4.1 Million DKK | -94.0% |
| 2003 FY | 68.32 Million DKK | 0.0% |
| 2002 FY | - DKK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Agenus Inc. | 156.31 Million USD | -10439.043% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -10909833.775% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -47682.58% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| MiMedx Group, Inc. | 321.47 Million USD | -5024.472% |
| Novavax, Inc. | 983.7 Million USD | -1574.689% |
| Seer, Inc. | 15.18 Million USD | -108410.078% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -9950.392% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Ardelyx, Inc. | 124.45 Million USD | -13136.807% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -79269.821% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Fortress Biotech, Inc. | 84.51 Million USD | -19392.859% |
| Fortress Biotech, Inc. | 84.51 Million USD | -19392.859% |
| Geron Corporation | 237 Thousand USD | -6950954.852% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -6743.209% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -81742.118% |
| Incyte Corporation | 3.69 Billion USD | -345.767% |
| Innoviva, Inc. | 310.46 Million USD | -5206.268% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 83.57 Million USD | -19612.816% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -12445.502% |
| MEI Pharma, Inc. | 65.29 Million USD | -25129.337% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -28177442.119% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -2098498.726% |
| GlycoMimetics, Inc. | 10 Thousand USD | -164739900.0% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -70346.868% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -264542.57% |
| Pharming Group N.V. | 245.31 Million USD | -6615.42% |
| ContextLogic Inc. | 287 Million USD | -5640.07% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -136670.444% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -13994.557% |
| AlloVir, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -53060.799% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -643164.35% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -1193668.116% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -329479900.0% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -12669.256% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Chimerix, Inc. | 324 Thousand USD | -5084467.901% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 371.2 Million USD | -4337.967% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -14439.517% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -2415442.522% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -38381.663% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Precision BioSciences, Inc. | 48.72 Million USD | -33708.771% |
| Dyadic International, Inc. | 2.89 Million USD | -568202.95% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -51963.713% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -8364.57% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | -801.06% |
| Aptorum Group Limited | 431.37 Thousand USD | -3818824.47% |
| Bicycle Therapeutics plc | 26.97 Million USD | -60969.098% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -200167.445% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -6323892.322% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Alkermes plc | 1.66 Billion USD | -890.378% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -321406.635% |
| Jaguar Health, Inc. | 9.76 Million USD | -168673.691% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -1548208.271% |
| AbCellera Biologics Inc. | 38.02 Million USD | -43224.129% |
| PureTech Health plc | 3.33 Million USD | -494614.715% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -9247.905% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -2054014.713% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -67543.919% |
| AnaptysBio, Inc. | 17.15 Million USD | -95919.118% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 57.3 Million USD | -28647.426% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -26116.203% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -1060002.96% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -203710.466% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -187530.979% |
| ImmuCell Corporation | 17.47 Million USD | -94189.79% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -3885277.358% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -86382.23% |
| Opthea Limited | 261.85 Thousand USD | -6291071.967% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -172222.176% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -165701.127% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -25829.832% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -915122.222% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | -4037.075% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -596784.058% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -1962588.194% |
| Century Therapeutics, Inc. | 2.23 Million USD | -736991.723% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -78165.001% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -16176.404% |
| Autolus Therapeutics plc | 1.69 Million USD | -970100.236% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -35699.035% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -24226370.588% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -9574.881% |
| GRI Bio, Inc. | 21.76 Million USD | -75583.374% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -648486.252% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -773327.23% |
| INmune Bio, Inc. | 155 Thousand USD | -10628287.097% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -12867.161% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -735677.857% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -1647300.0% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -192061.437% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -6304.037% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -470585.714% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -1042558.228% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -211975.18% |
| Histogen Inc. | 3.76 Million USD | -436992.067% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -2824509.803% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -15113661.468% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -4205723.409% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -48525.993% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -240291.07% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -10343.239% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -11298939.781% |
| Apollomics, Inc. | 821 Thousand USD | -2006477.345% |
| Amarin Corporation plc | 306.91 Million USD | -5267.68% |
| Mesoblast Limited | 5.9 Million USD | -279025.72% |
| Turnstone Biologics Corp. | 19.3 Million USD | -85230.985% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -20861.421% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -9286.199% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | -800.116% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -21298.418% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | -4053.902% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -1237616.003% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -11674.628% |
| Insmed Incorporated | 305.2 Million USD | -5297.63% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -88062.261% |
| OmniAb, Inc. | 34.16 Million USD | -48120.349% |
| Alector, Inc. | 97.06 Million USD | -16872.657% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -12940.966% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -15994074.757% |
| Zai Lab Limited | 266.71 Million USD | -6076.538% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -6938.968% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -12672207.692% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -94323.11% |
| Veracyte, Inc. | 361.05 Million USD | -4462.79% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -358207.252% |
| FibroGen, Inc. | 147.75 Million USD | -11049.764% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -11145666.381% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | -329.659% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -3922280.952% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | -4226.315% |
| TG Therapeutics, Inc. | 233.66 Million USD | -6950.355% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | -429.881% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -1057281.258% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -48133.055% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -19322.535% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -28588.353% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | -3693.676% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -36708.473% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | -4870.852% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -29854919.935% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -63251.792% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -183044344.444% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -497433.624% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | -25.591% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -13490793.606% |
| Pluri Inc. | 326 Thousand USD | -5053274.233% |
| Prothena Corporation plc | 91.37 Million USD | -17929.988% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -27228.677% |
| Celularity Inc. | 22.77 Million USD | -72246.406% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -299972.86% |
| MeiraGTx Holdings plc | 14.01 Million USD | -117428.715% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -6504.712% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -25678.891% |
| Blueprint Medicines Corporation | 249.38 Million USD | -6505.983% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -225633.078% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -45314.197% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -329666.699% |
| Cytokinetics, Incorporated | 7.53 Million USD | -218678.22% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -789900.93% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -13100.849% |
| Evogene Ltd. | 5.64 Million USD | -291992.199% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -164755.399% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -176982.662% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -343108.333% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -45000.884% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -5246396.815% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -823600.0% |
| MediciNova, Inc. | 1 Million USD | -1647300.0% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -673132.53% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -96536671.169% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -5987.953% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | -1656.623% |
| Mereo BioPharma Group plc | 10 Million USD | -164640.0% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -288007.73% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -79396.212% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -5995.634% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -587208.378% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | -3315.185% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -17340952.632% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -346137.915% |
| Kezar Life Sciences, Inc. | 7 Million USD | -235242.857% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -78467.341% |
| aTyr Pharma, Inc. | 353 Thousand USD | -4666755.524% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -105985.389% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -5246396.815% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -136611559.342% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | -1886.607% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -7282577.889% |
| UroGen Pharma Ltd. | 82.71 Million USD | -19817.063% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -10616.121% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -59580370.163% |
| Orgenesis Inc. | 530 Thousand USD | -3108201.887% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -9686.263% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -6496648.471% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -8451.703% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -7282577.889% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -96536671.169% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -1095974.518% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -316418.261% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -150223.935% |
| scPharmaceuticals Inc. | 13.59 Million USD | -121094.733% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -164261.967% |
| Daré Bioscience, Inc. | 2.8 Million USD | -586604.94% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -8953160.87% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | -570.007% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -142162.522% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -27356.667% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -55749.747% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | -580.962% |
| DBV Technologies S.A. | 15.72 Million USD | -104643.133% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | -140.567% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -205670.672% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -11242.762% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -163186.748% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -239243.31% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -27941.328% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -2553311.782% |
| Adagene Inc. | 18.11 Million USD | -90858.828% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -1522450.832% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -5601.431% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -6489.389% |
| SciSparc Ltd. | 2.87 Million USD | -572112.574% |
| Vericel Corporation | 197.51 Million USD | -8240.59% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -278931.165% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -27538.157% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -64387.591% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -16930.03% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -16310.491% |
| ADMA Biologics, Inc. | 258.21 Million USD | -6279.955% |
| Clene Inc. | 654 Thousand USD | -2518860.245% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -65329.966% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -36857.936% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -32848.0% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -15396161.682% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -19015.804% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -22532452.796% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -28088.149% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -140008.862% |
| Trevena, Inc. | 3.12 Million USD | -527068.0% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | -2167.781% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -261891.094% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -209067.09% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -2648453.055% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -302619.588% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -23386.307% |
| Celularity Inc. | 22.77 Million USD | -72246.406% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -410415.824% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -10531868.623% |
| Cibus, Inc. | 1.81 Million USD | -906559.329% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -457511.111% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -229887.435% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -856137.006% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | -1991.546% |
| Eyenovia, Inc. | 3787.00 USD | -435014423.369% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -6891.262% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -14833.058% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -3375719.672% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -20699.455% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -1820132.938% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -243274.206% |
| Royalty Pharma plc | 2.35 Billion USD | -599.665% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -2244708.693% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -44599.498% |
| Humacyte, Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -9690488.235% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -1368172.425% |
| Notable Labs, Ltd. | 310 Thousand USD | -5314093.548% |
| Liquidia Corporation | 17.48 Million USD | -94101.738% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -1522450.832% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -90710.87% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -884647.583% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -961832.039% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | -607.798% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -22848087.29% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -346137.915% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -54913233.333% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -103882.832% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -25360.952% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -3867036.15% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | -4025.141% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -49136.379% |
| Peak Bio, Inc. | 367.87 Thousand USD | -4478027.2% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -59890.532% |
| Benitec Biopharma Inc. | 216 Thousand USD | -7626751.852% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -1859267.946% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -1243.373% |
| Immunome, Inc. | 14.01 Million USD | -117420.331% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -994106.397% |
| CervoMed Inc. | 7.14 Million USD | -230470.961% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -335214.472% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -582844.091% |
| Moolec Science SA | 905.04 Thousand USD | -1820132.938% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -1979924.279% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -669561.458% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -747698.457% |
| Lumos Pharma, Inc. | 2.05 Million USD | -803117.942% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -40351.627% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -789900.93% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -8075390.196% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -13728233.333% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -6589500.0% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | -4261.559% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -8739.216% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -41085.0% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -1385434.062% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -106520.931% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -2890075.439% |
| HCW Biologics Inc. | 2.84 Million USD | -579604.229% |
| XOMA Corporation | 4.75 Million USD | -346137.915% |
| Nektar Therapeutics | 90.12 Million USD | -18179.665% |
| Arvinas, Inc. | 78.5 Million USD | -20885.987% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -37386.063% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -532349.903% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -2518860.245% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -940733.809% |
| Synlogic, Inc. | 3.37 Million USD | -488597.716% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -4478027.2% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -82505.425% |
| Krystal Biotech, Inc. | 50.69 Million USD | -32393.738% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -11181.012% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -302341.711% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -3663907.366% |
| MannKind Corporation | 198.96 Million USD | -8179.973% |
| Ikena Oncology, Inc. | 9.16 Million USD | -179747.162% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -14420.934% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -5677.452% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -411849900.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -32746.177% |
| REGENXBIO Inc. | 90.24 Million USD | -18155.358% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -738472.172% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -223155.184% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -2181886.755% |
| Longeveron Inc. | 709 Thousand USD | -2323454.302% |
| Repare Therapeutics Inc. | 51.13 Million USD | -32117.941% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | -1224.984% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -142162.522% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -7844661.905% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | -66.923% |
| Denali Therapeutics Inc. | 330.53 Million USD | -4884.101% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -100986.35% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -609370.958% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -21176.541% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -10807483.809% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -110322.951% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -2440492.593% |
| OmniAb, Inc. | 34.16 Million USD | -48120.349% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -77417.41% |
| Lipocine Inc. | -2.85 Million USD | 577969.229% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -735677.857% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -19865.823% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -18955.0% |
| Ocugen, Inc. | 6.03 Million USD | -272829.092% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -1424986.505% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -45554.584% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -274365.755% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -2602008.349% |
| Dominari Holdings Inc. | 2.03 Million USD | -807845.071% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | -1321.324% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -61317.44% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | -2730.477% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -130697.936% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -3453568.763% |
| Iterum Therapeutics plc | - USD | -Infinity% |